BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33229892)

  • 1. Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats.
    Douton JE; Augusto C; Stoltzfus B; Carkaci-Salli N; Vrana KE; Grigson PS
    Behav Pharmacol; 2021 Jun; 32(4):265-277. PubMed ID: 33229892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, reduces cue- and drug-induced fentanyl seeking in rats.
    Urbanik LA; Acharya NK; Grigson PS
    Brain Res Bull; 2022 Oct; 189():155-162. PubMed ID: 36031011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of glucagon-like peptide-1 receptors in the nucleus accumbens attenuates cocaine seeking in rats.
    Hernandez NS; O'Donovan B; Ortinski PI; Schmidt HD
    Addict Biol; 2019 Mar; 24(2):170-181. PubMed ID: 29226617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats.
    Evans B; Stoltzfus B; Acharya N; Nyland JE; Arnold AC; Freet CS; Bunce SC; Grigson PS
    Brain Res Bull; 2022 Oct; 189():163-173. PubMed ID: 36038016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glucagon-like peptide-1 receptor agonist, exendin-4, reduces sexual interaction behaviors in a brain site-specific manner in sexually naïve male mice.
    Vestlund J; Jerlhag E
    Horm Behav; 2020 Aug; 124():104778. PubMed ID: 32450068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 receptor agonist, liraglutide, reduces heroin self-administration and drug-induced reinstatement of heroin-seeking behaviour in rats.
    Douton JE; Horvath N; Mills-Huffnagle S; Nyland JE; Hajnal A; Grigson PS
    Addict Biol; 2022 Mar; 27(2):e13117. PubMed ID: 34802173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala.
    Alvarez-Jaimes L; Polis I; Parsons LH
    Neuropsychopharmacology; 2008 Sep; 33(10):2483-93. PubMed ID: 18059440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues.
    Zhou W; Liu H; Zhang F; Tang S; Zhu H; Lai M; Kalivas PW
    Neuroscience; 2007 Feb; 144(4):1209-18. PubMed ID: 17184925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of blockade of dopamine D1-family receptors in nucleus accumbens core or shell on reinstatement of heroin seeking induced by contextual and discrete cues.
    Bossert JM; Poles GC; Wihbey KA; Koya E; Shaham Y
    J Neurosci; 2007 Nov; 27(46):12655-63. PubMed ID: 18003845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats.
    Zhang Y; Rahematpura S; Ragnini KH; Moreno A; Stecyk KS; Kahng MW; Milliken BT; Hayes MR; Doyle RP; Schmidt HD
    Neuropharmacology; 2021 Jul; 192():108599. PubMed ID: 33965397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats.
    Hernandez NS; Ige KY; Mietlicki-Baase EG; Molina-Castro GC; Turner CA; Hayes MR; Schmidt HD
    Neuropsychopharmacology; 2018 Sep; 43(10):2000-2008. PubMed ID: 29497166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dopamine D(1)-family receptors in dorsolateral striatum in context-induced reinstatement of heroin seeking in rats.
    Bossert JM; Wihbey KA; Pickens CL; Nair SG; Shaham Y
    Psychopharmacology (Berl); 2009 Sep; 206(1):51-60. PubMed ID: 19506837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats.
    Zhang Y; Kahng MW; Elkind JA; Weir VR; Hernandez NS; Stein LM; Schmidt HD
    Neuropsychopharmacology; 2020 Feb; 45(3):451-461. PubMed ID: 31581176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents.
    Vallöf D; Kalafateli AL; Jerlhag E
    Psychoneuroendocrinology; 2019 May; 103():284-295. PubMed ID: 30771711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLP-1 receptor signaling in the laterodorsal tegmental nucleus attenuates cocaine seeking by activating GABAergic circuits that project to the VTA.
    Hernandez NS; Weir VR; Ragnini K; Merkel R; Zhang Y; Mace K; Rich MT; Christopher Pierce R; Schmidt HD
    Mol Psychiatry; 2021 Aug; 26(8):4394-4408. PubMed ID: 33257815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute glucagon-like peptide-1 receptor agonist liraglutide prevents cue-, stress-, and drug-induced heroin-seeking in rats.
    Douton JE; Acharya NK; Stoltzfus B; Sun D; Grigson PS; Nyland JE
    Behav Pharmacol; 2022 Aug; 33(5):364-378. PubMed ID: 35695511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Site-Specific Inhibitory Effects of the GLP-1 Analogue Exendin-4 on Alcohol Intake and Operant Responding for Palatable Food.
    Colvin KJ; Killen HS; Kanter MJ; Halperin MC; Engel L; Currie PJ
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of glucagon-like peptide-1 receptors and skilled reach foraging.
    Vestlund J; Bergquist F; Licheri V; Adermark L; Jerlhag E
    Addict Biol; 2021 May; 26(3):e12953. PubMed ID: 32770792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-dependent divergence in the effects of GLP-1 agonist exendin-4 on alcohol reinforcement and reinstatement in C57BL/6J mice.
    Díaz-Megido C; Thomsen M
    Psychopharmacology (Berl); 2023 Jun; 240(6):1287-1298. PubMed ID: 37106129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs.
    Bornebusch AB; Fink-Jensen A; Wörtwein G; Seeley RJ; Thomsen M
    eNeuro; 2019; 6(2):. PubMed ID: 31058214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.